Glossary
Liraglutide
Updated March 29, 2026
Liraglutide is a GLP-1 receptor agonist that reduces appetite and helps stabilize blood sugar through daily injections. Compared to newer weekly injectables like semaglutide, liraglutide produces more moderate appetite suppression (roughly 5-8% body weight loss in trials vs. 15-17% for semaglutide). For people who train, this milder profile can be an advantage because it is easier to maintain adequate intake, though you still need to actively protect protein and training structure.
Brand map
| Brand | Form | Dosing rhythm | Titration range | Physique-relevant positioning |
|---|
| Saxenda | daily injection | once daily, any time | 0.6mg to 3.0mg over 5 weeks (increase by 0.6mg each week) | weight-management approved, designed for fat-loss outcomes |
| Victoza | daily injection | once daily, any time | 0.6mg to 1.8mg over 2+ weeks | diabetes-focused, where weight loss is a secondary effect |
How liraglutide differs from semaglutide and tirzepatide for physique goals
| Factor | Liraglutide | Semaglutide | Tirzepatide |
|---|
| Dosing frequency | daily injection | weekly injection or daily tablet | weekly injection |
| Appetite suppression | moderate | strong | very strong |
| Typical weight loss in trials | 5-8% body weight | 15-17% body weight | 20-22.5% body weight |
| Under-fueling risk | lower (easier to eat enough) | moderate | highest (strong suppression makes skipping meals easy) |
| Dose adjustment flexibility | can adjust by 0.6mg increments daily | fixed weekly dose with larger steps | fixed weekly dose with larger steps |
| Best fit for training people | when moderate appetite support is enough and you want finer dose control | when stronger suppression is needed and weekly dosing fits your routine | when maximum suppression is acceptable and you can commit to strict meal structure |
Physique-first use model
| Goal | What to emphasize | Specific targets | What to avoid |
|---|
| Fat loss with lean retention | moderate deficit, stable protein, consistent lifting | 15-25% deficit (300-500 cal/day), 1.2-1.6 g/kg protein, 3-4 lifting sessions per week | aggressive restriction that creates missed meals |
| Maintenance or recomposition | stable weekly intake and training consistency | maintenance calories, 1.2-1.4 g/kg protein, 14-day weight trend windows | chasing short-window scale changes |
| Training output focus | carbs near sessions and stable hydration | 30-40g carbs pre-workout, 64-80 oz water daily | skipping recovery meals because appetite is low |
Nutrition levers
| Lever | Specific target | Practical examples | Expected signal |
|---|
| Protein floor | 1.2-1.6 g/kg daily, 25-35g per meal | 4 oz chicken breast (~35g), 6 oz salmon (~34g), 1 cup Greek yogurt (~20g), 2 eggs (~12g) | better strength retention and fewer hunger rebounds |
| Fiber ramp | 25-30g daily, increase by 3-5g per week | 1/2 cup lentils (~8g), 1 oz chia seeds (~10g), 1 medium apple (~4g), 1 cup broccoli (~5g) | steadier digestion and more predictable appetite |
| Hydration | 64-80 oz daily, plus 16-20 oz per hour of training | 32 oz bottle x2 before dinner, extra during sessions | fewer headaches and less dizziness |
| Meal planning | pre-decide 2-3 default meals per day | prep containers: chicken + rice + greens, Greek yogurt + granola + berries | fewer missed meals and less week-to-week drift |
| Injection timing | consistent daily timing, ideally separate from pre-workout window | inject at the same time each day (morning or evening) to keep appetite effects predictable | more consistent appetite suppression and fewer surprise low-appetite windows during training |
Side-effect management
| Issue | Why it shows up | Foods and actions that help |
|---|
| Nausea (most common in first 1-2 weeks at each dose level) | GI tract adjusting to GLP-1 stimulation | eat slowly over 15-20 min, choose bland foods (plain rice, toast, broth, cold yogurt), avoid greasy or fried foods, keep meals under 400 cal until tolerance improves |
| Constipation | low food volume plus low fluid intake | add 16-24 oz water daily, ramp fiber gradually (ground flaxseed, chia seeds, cooked vegetables) |
| Injection site reactions | repeated injection in the same area | rotate between abdomen, thigh, and upper arm, avoid injecting within 1 inch of the previous site |
Training integration on liraglutide
Daily dosing means appetite suppression is more consistent than weekly injectables (no "peak and trough" pattern). This makes meal timing more predictable but also means there are no low-suppression days where eating more feels natural.
| Training context | Pre-workout nutrition (60-90 min before) | Post-workout nutrition (within 2 hours) | Adjustment cues |
|---|
| Standard session | 20-40g carbs + 15-20g protein (banana + protein shake, toast + peanut butter) | 30-40g protein + 20-40g carbs (chicken + rice, protein shake + fruit) | if sessions feel flat for 2+ workouts, add 15-20g more carbs pre-training |
| Low-appetite day | minimum 15-20g carbs (half banana, rice cake with honey) | 25-30g protein in any tolerable format (shake, yogurt) | reduce volume by 1-2 sets rather than skipping the session |
| Dose increase week | nausea often spikes for 3-7 days after each 0.6mg step up | prioritize protein (25-30g) even if total calories are lower | keep meals smaller and more frequent until GI tolerance stabilizes |
Body composition monitoring
| What to track | How to measure | Frequency | Decision rule |
|---|
| Weight trend | morning weigh-in under same conditions, 14-day rolling average | daily weigh-in, weekly trend review | do not change targets unless the trend stalls for 14+ days |
| Waist and hip circumference | fabric tape at navel and widest hip point | every 2 weeks | waist dropping while weight is stable suggests recomposition |
| Strength in core lifts | track top sets in squat, bench, row, or deadlift | every session | strength dropping across 2+ weeks signals under-fueling |
| Limb circumference | mid-bicep and mid-thigh with fabric tape | monthly | large drops alongside rapid weight loss suggest lean mass loss |
Safety and escalation thresholds
| Signal pattern | Why it matters | Next step |
|---|
| Severe abdominal pain with persistent vomiting | pancreatitis or gallbladder complication risk | urgent clinical evaluation |
| Persistent dehydration signs or inability to keep fluids down | kidney and electrolyte stress risk | seek medical guidance |
| Severe weakness or confusion in a diabetes-medication stack | systemic risk | urgent evaluation |